Federal government approves nationwide transition to electronic prescriptions and medication plans to reduce errors and improve patient safety
"The new regulation will reduce the risk of errors when dispensing medication."
"The e-prescription would also help to reduce counterfeiting and the misuse of multiple prescriptions."
The era of handwritten scrawls and paper trails is officially dead. In a decisive move on Wednesday, September 3, 2025, the Federal Council adopted a sweeping proposal that mandates the transition to electronic prescriptions across Switzerland. This is not merely an administrative update; it is a fundamental overhaul of the Therapeutic Products Act designed to drag the medical system into the 21st century. The government is asserting its authority to modernize infrastructure that has lagged behind for too long.
By adopting the proposal from parliament, the Federal Council is signaling that patient safety can no longer rely on analog methods. The mandate requires doctors to issue prescriptions electronically, effectively eliminating the manual processes that have historically plagued the system with inefficiencies. This bold step aligns with the proposals submitted for consultation at the end of 2023, proving that the government is committed to executing a long-term vision for digital health. The message is clear: the Swiss healthcare system is digitizing, and compliance is not optional.
Safety is the paramount driver of this reform. The Federal Council explicitly stated in its press release that the new regulation will drastically reduce the risk of errors when dispensing medication. Misunderstandings between prescribers and pharmacists—often caused by illegible handwriting or lost paperwork—are being systematically eradicated. The digital chain of custody ensures that what the doctor prescribes is exactly what the patient receives.
Furthermore, the government is launching a direct offensive against the black market. The e-prescription system is engineered to act as a fortress against counterfeiting and the misuse of multiple prescriptions. By centralizing the data, the system prevents "doctor shopping," where individuals obtain the same prescription from multiple providers. This creates an unprecedented level of oversight, ensuring that controlled substances and critical medications are dispensed with absolute accountability. The government is not just streamlining a process; it is closing the loopholes that criminals and addicts have exploited for years.
Patients are at the center of this technological leap. Under the new bill, Swiss citizens will no longer be left in the dark about their treatment regimens. The legislation mandates the introduction of a comprehensive electronic medication plan. This digital document will contain a precise list of medicines to be taken, coupled with clear, accessible information on their use. This is a massive victory for patient autonomy and adherence.
Gone are the days of fragmented information. This electronic plan serves as a single source of truth for the patient, the pharmacist, and the physician. It ensures that everyone involved in the care continuum is operating with the same data. The government's push ensures that the population has rapid access not only to their own data but also to innovative forms of treatment. This transparency is critical for an aging population managing complex medication schedules, transforming a passive patient experience into an active, informed partnership.
The reform extends its reach deep into the high-pressure environment of Swiss hospitals. The government is not asking, but obliging hospitals to utilize electronic systems for calculating medication dosages. This removes the human element from complex mathematical calculations where a single decimal point error can be fatal. By automating dosage calculations, the Federal Council is enforcing a standard of precision that manual methods simply cannot match.
This draft legislation also grants the authority to extend these obligations to other outpatient areas, suggesting that this is just the beginning of a wider rollout. Furthermore, the government is clearing the regulatory path for advanced therapy medicinal products, ensuring rapid access to cutting-edge treatments. This forward-looking approach demonstrates that Switzerland is preparing its infrastructure not just for the medicines of today, but for the personalized, complex therapies of tomorrow. The integration of algorithmic safety checks in hospitals represents a critical safeguard for every patient entering the Swiss medical system.